Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.
Clinical details
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
Multimodality DICOM image management, quantitative analysis, optional cardiovascular MR mapping and flow analysis, and therapy-response lesion tracking for trained clinicians.
DICOM and non-DICOM radiological images, including multi-slice and multi-phase CT, MR, ultrasound, x-ray and mammography studies; optional cardiovascular MR includes velocity-encoded data.
Cloud image display with 2D, 3D and MIP views, measurements, reports, secondary capture, optional T1/T2 and 4D-flow cardiovascular MR outputs, and lesion tracking or Lung-RADS reporting workflows.
Requires trained healthcare professionals and user review; optional cardiovascular MR was tested at 1.5T and 3.0T; optional modules and third-party algorithms are not all part of this exact submission.
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
FDA materials describe upload from PACS or scanner and report/secondary-capture workflows; the Tempus family material was readable during the Sept 7 review and describes PACS, EHR, worklist, notification and dictation integration, but does not establish the exact K252539 configuration. A later automated request returned HTTP 429, which is treated as rate limiting rather than absence of product information.
The reviewed sources do not establish a current exact-release security attestation or contract scope.
Training and support
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-08-13
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Monitoring and change control
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-08-13
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Cloud delivery
The exact FDA summary describes a hosted application accessed through Chrome.
Current Tempus Pixel family material describes PACS, EHR, worklist, notification and dictation integration; exact K252539 configuration is not established.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA-reviewed non-clinical T1/T2 inline-map and workflow validation supports the exact release; the FDA summary states there was no clinical study for the modified device.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
T1/T2 inline map validation
DesignNon-clinical comparative bench validation
Population30 cardiovascular MR series across manufacturer and scanner types, with four regions of interest per series
Scopeexact submission
Tested versionTempus Pixel release reviewed in K252539
Samplen=30
IndependenceSponsor or vendor study
K252539 FDA 510(k) summary
The FDA summary reports software verification and validation passed and states no clinical study was performed for the modified device.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-07
No numeric price was published in the reviewed sources.
Reimbursement and coding
Research pending
Needs research
Exact FDA submission
Checked 2026-08-31
Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Open questions to take to the vendor
Verify security and privacy controls: The reviewed sources do not establish a current exact-release security attestation or contract scope.
Verify training: Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Verify pricing and total cost: No numeric price was published in the reviewed sources.
Verify reimbursement and coding relevance: Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.
Verify local validation and lifecycle monitoring: Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Verify recalls and postmarket safety signals: No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
23Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The stored candidate metadata contained empty PubMed and clinical-trial ID arrays; metadata was screened, not full-text or registry-reviewed. The stored recall candidate record was empty and no event was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor manual, peer reviewed publication, clinical trial registry, recall database, pubmed, clinical trials, openfda device recall
Sources & history
How this profile was documented
Open the ledger for source dates, scope, and research-record updates.
View source ledger and history9 sources - 2 history items
Contour ProtégéAI+ processes CT and MR DICOM images and generates contours for quantitative analysis, adaptive therapy, image registration, transfer to radiotherapy planning, and...
Modality
Radiological images; modality varies or is not specified in FDA list
Synapse PACS version 7.5 provides primary processing and presentation of DICOM and supported non-DICOM images with measurement, segmentation, fusion, volume rendering, reporting,...
Modality
Radiological images; modality varies or is not specified in FDA list
Ziostation2 is customer-hardware image-processing software for viewing, quantifying, manipulating, communicating, printing, and managing many radiological image types, with...
Modality
Radiological images; modality varies or is not specified in FDA list